Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New site-agnostic therapy shrank tumors in people with a variety of cancers with NTRK gene fusions as well as ROS1-positive lung cancer.
How true is his statement? These facts add context.
These robots help young cancer patients express their emotions.
“SNL” alum and cancer survivor Vanessa Bayer has written a book with lessons for kids—and adults.
The Childhood Cancer Data Initiative aims to change the course of how cancer in young people is prevented, diagnosed and treated.
Some hospitals offer parents the choice to transport their dying children out of the intensive care unit so that they can die at home.
In a win for abortion opponents, the Trump administration limits funding of research using fetal tissue.
All 12 treated children with NTKR, ROS1 or ALK gene abnormalities showed partial or compete tumor shrinkage.
Phil Catudal credits his early cancer experience with his motivational approach to wellness.
“It is unthinkable that a doctor could tell you that there is nothing that can be done for your child,” says Kathryn R. Taylor, PhD.
The trial is part of an effort by the Children’s Oncology Group and others to evaluate treatment regimens for children with cancer.
Given the long timeline needed for human studies, people today should not expect this technology to be proven and fully approved for years.
Angela J. Waanders, MD, MPH, is tackling pediatric brain cancer.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
Experts say the regimen will become the standard of care for people up to age 40 who are newly diagnosed with acute lymphoblastic leukemia.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.